GSK

$0.00

(

+0.00%

)
Quote details

stock

GlaxoSmithKline PLC ADR

NYSE | GSK

48.88

USD

(

+0.00%

)

At Close (As of Jan 1, 1970)

$98.21B

Market Cap

13.68

P/E Ratio

3.54

EPS

$49.31

52 Week High

$30.41

52 Week Low

HEALTHCARE

Sector

GSK Chart

Recent Chart
Price Action

GSK Technicals

Tags:

GSK Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (GBP)
Gross Profit $22B
Total Revenue $31B
Cost Of Revenue $9B
Costof Goods And Services Sold $9B
Operating Income $4B
Selling General And Administrative $11B
Research And Development $6.4B
Operating Expenses $18B
Investment Income Net -
Net Interest Income -$603M
Interest Income $60M
Interest Expense $658M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.6B
Income Before Tax $3.5B
Income Tax Expense $526M
Interest And Debt Expense -
Net Income From Continuing Operations $3B
Comprehensive Income Net Of Tax -
Ebit $4.1B
Ebitda $6.7B
Net Income $2.6B

Revenue & Profitability

Earnings Performance

GSK Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (GBP)
Total Assets $59B
Total Current Assets $17B
Cash And Cash Equivalents At Carrying Value $3.7B
Cash And Short Term Investments $3.7B
Inventory $5.7B
Current Net Receivables $6B
Total Non Current Assets $42B
Property Plant Equipment $10B
Accumulated Depreciation Amortization Ppe -
Intangible Assets $16B
Intangible Assets Excluding Goodwill $16B
Goodwill $7B
Investments -
Long Term Investments -
Short Term Investments $21M
Other Current Assets $1.6B
Other Non Current Assets -
Total Liabilities $46B
Total Current Liabilities $22B
Current Accounts Payable $3.5B
Deferred Revenue -
Current Debt -
Short Term Debt $2.3B
Total Non Current Liabilities $25B
Capital Lease Obligations $1.1B
Long Term Debt $14B
Current Long Term Debt $2.2B
Long Term Debt Noncurrent -
Short Long Term Debt Total $17B
Other Current Liabilities $15B
Other Non Current Liabilities $6.1B
Total Shareholder Equity $14B
Treasury Stock -
Retained Earnings $7.8B
Common Stock $1.3B
Common Stock Shares Outstanding $2.1B

yearly Cash Flow (As of Dec 31, 2024)

Field Value (GBP)
Operating Cashflow $6.6B
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.6B
Capital Expenditures $3B
Change In Receivables -
Change In Inventory -$294M
Profit Loss -
Cashflow From Investment -$1.2B
Cashflow From Financing -$4.7B
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $2.4B
Dividend Payout Common Stock $2.4B
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $20M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $3B

yearly Income Statement (As of Dec 31, 2024)

Field Value (GBP)
Gross Profit $22B
Total Revenue $31B
Cost Of Revenue $9B
Costof Goods And Services Sold $9B
Operating Income $4B
Selling General And Administrative $11B
Research And Development $6.4B
Operating Expenses $18B
Investment Income Net -
Net Interest Income -$603M
Interest Income $60M
Interest Expense $658M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.6B
Income Before Tax $3.5B
Income Tax Expense $526M
Interest And Debt Expense -
Net Income From Continuing Operations $3B
Comprehensive Income Net Of Tax -
Ebit $4.1B
Ebitda $6.7B
Net Income $2.6B

Dividends

Field Value
Ex Dividend Date 2025-11-14
Declaration Date 2025-10-29
Record Date 2025-11-14
Payment Date 2026-01-08
Amount 0.417088

GSK Profile

GlaxoSmithKline PLC ADR Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - GENERAL

GlaxoSmithKline PLC (GSK) is a leading global biopharmaceutical company based in Brentford, UK, focused on enhancing health outcomes through its pioneering pharmaceuticals, vaccines, and consumer healthcare offerings. With a strong emphasis on research and development, GSK addresses critical global health challenges and maintains a diversified portfolio across key therapeutic areas. The company’s strategic commitment to innovation and sustainability not only positions it as a prominent player in the healthcare sector but also presents compelling investment opportunities for institutional investors looking to engage with the dynamic biopharmaceutical industry.

ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.57%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
KIND
+9.48%
$2.77
NXDR
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
KVUE
0.00%
$17.32
TSLA
-1.01%
$446.89
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
WBD
-0.13%
$29.49
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
RR
+12.77%
$4.68
BTG
0.00%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
NIO
+1.98%
$5.13
T
-0.36%
$24.30
LNW
-3.71%
$86.22
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
PFE
+0.07%
$25.80
SRM
+53.27%
$10.30
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RKLB
+10.44%
$63.53
QBTS
+4.40%
$27.98
RIG
-0.46%
$4.28
JBLU
-2.78%
$4.89
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
SNAP
-3.53%
$7.64
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
NCLH
+6.80%
$20.55
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
UBER
+1.52%
$85.44
SMCI
-2.52%
$34.02
KO
-1.56%
$69.11
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CNQ
-1.72%
$33.14
VZ
+0.75%
$40.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82
ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.57%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
KIND
+9.48%
$2.77
NXDR
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
KVUE
0.00%
$17.32
TSLA
-1.01%
$446.89
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
WBD
-0.13%
$29.49
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
RR
+12.77%
$4.68
BTG
0.00%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
NIO
+1.98%
$5.13
T
-0.36%
$24.30
LNW
-3.71%
$86.22
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
PFE
+0.07%
$25.80
SRM
+53.27%
$10.30
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RKLB
+10.44%
$63.53
QBTS
+4.40%
$27.98
RIG
-0.46%
$4.28
JBLU
-2.78%
$4.89
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
SNAP
-3.53%
$7.64
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
NCLH
+6.80%
$20.55
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
UBER
+1.52%
$85.44
SMCI
-2.52%
$34.02
KO
-1.56%
$69.11
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CNQ
-1.72%
$33.14
VZ
+0.75%
$40.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.